Indefinite Delivery Contract 36E79721D0047

Award Date 9/24/21
Last Date to Order 9/23/24
Awardee
Avkare LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC is for the supply of Acetazolamide Tablets in 125mg and 250mg strengths. The contract has a ceiling value of $2,075,624.60 and a period of performance from July 31, 2022 to July 30, 2023, with four one-year option periods. The contract supports the procurement needs of the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) for...
This single-award Indefinite Delivery Contract (IDC) was issued by the National Acquisition Center, a civilian agency of the U.S. Department of Veterans Affairs (VA), to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The $11.95 million contract has a 1-year ordering period from 12/11/2022 to 12/10/2023, with four 1-year option periods, for a total potential period of performance through 12/10/2025. The contract is to provide an uninterrupted supply of Acitretin...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The single-award, $1,099,043 contract provides for the supply of Verapamil IR tablets to the VA, Bureau of Prisons (BOP), and Indian Health Service (IHS) over a base year from June 1, 2020 to May 31, 2021, with four one-year option periods. The contract was competed as an unrestricted...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a for-profit limited liability company based in Pulaski, Tennessee. The contract, valued at $4,619,331.60, is for the supply of phenytoin sodium extended-release capsules to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a one-year base period with four one-year option periods, and allows the...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The single-award contract, which has a ceiling value of $16,283,304.30, is for the supply of Cyclobenzaprine HCL 10mg tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a base year with four one-year option periods, effective May 15,...
The Department of Veterans Affairs National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Avkare LLC, a pharmaceutical and medical supply company, for the procurement of Ranolazine Tablets, SA. The contract has a ceiling value of $26,094,915.10 and a period of performance from November 20, 2020 through November 19, 2021, with four one-year option periods. The contract aims to provide an uninterrupted supply of Ranolazine Tablets to the VA, Department of Defense, Bureau of...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $7,970,583.75 and a period of performance from January 30, 2024 to January 29, 2026. The contract is for the uninterrupted supply of Valganciclovir HCL 450mg Tablets, which will be distributed through the VA and Department of Defense's (DoD)...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $24,898,277.30 and a period of performance from June 23, 2025 to June 22, 2026. The contract is for the supply of Mycophenolate Mofetil capsules and tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The estimated...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. federal government, to Avkare LLC, a pharmaceutical and medical supply company. The contract has a ceiling value of $21,739,614.15 and a period of performance from June 21, 2021 to June 20, 2026, with an initial one-year base period and four one-year option periods. The contract is for the delivery of Carbidopa/Levodopa tablets in various sizes to support the healthcare...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract is for the supply of Abiraterone Acetate 250mg Tablets to the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract has a one-year base period with four one-year option periods, for a total ceiling value of...

The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Avkare LLC for the supply of Cinacalcet HCL tablets. The contract has a $2,542,904.80 ceiling value and a period of performance from September 24, 2021 to September 23, 2022, with four one-year option periods.

The contract aims to provide an uninterrupted source of Cinacalcet HCL tablets in 30mg, 60mg, and 90mg strengths to support the healthcare needs of the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). Avkare, a for-profit limited liability company, will distribute the pharmaceutical products through the VA's and DoD's respective Pharmaceutical Prime Vendor programs. This IDC award follows a pre-solicitation notice issued by the VA, which indicated the agency would competitively award a single contract for these medication requirements without any set-asides.

Generated 8/18/24, 12:01 AM